Aspiriant LLC’s ProShares S&P 500 Dividend Aristocrats ETF NOBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Sell
8,104
-1,108
-12% -$60K 0.01% 260
2026
Q1
$488K Hold
9,212
0.01% 222
2025
Q4
$479K Sell
9,212
-198
-2% -$10.2K 0.01% 218
2025
Q3
$485K Sell
9,410
-774
-8% -$40K 0.01% 202
2025
Q2
$513K Hold
10,184
0.02% 193
2025
Q1
$520K Buy
10,184
+1,330
+15% +$67.5K 0.02% 189
2024
Q4
$441K Hold
8,854
0.02% 199
2024
Q3
$473K Sell
8,854
-786
-8% -$39.9K 0.02% 190
2024
Q2
$463K Hold
9,640
0.02% 195
2024
Q1
$489K Sell
9,640
-1,696
-15% -$81.7K 0.02% 201
2023
Q4
$540K Hold
11,336
0.02% 183
2023
Q3
$502K Sell
11,336
-540
-5% -$25.4K 0.03% 178
2023
Q2
$560K Sell
11,876
-242
-2% -$11.1K 0.03% 172
2023
Q1
$553K Buy
12,118
+242
+2% +$11K 0.03% 168
2022
Q4
$534K Hold
11,876
0.03% 172
2022
Q3
$474K Sell
11,876
-266
-2% -$11.8K 0.02% 170
2022
Q2
$518K Buy
+12,142
New +$553K 0.03% 163

Other funds holding NOBL

Aspiriant LLC's NOBL Position: Q2 2026 in Review

Aspiriant LLC reduced its ProShares S&P 500 Dividend Aristocrats ETF (NOBL) stake by 12% in Q2 2026, selling an estimated $60K and leaving 8,104 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #260.

Aspiriant LLC first reported a position in NOBL in Q2 2022 and has held it in 17 quarters since. The position peaked at $560K in Q2 2023. 191 funds tracked by Wall St. Rank hold NOBL as of Q2 2026.

  • Aspiriant LLC held 8,104 shares of ProShares S&P 500 Dividend Aristocrats ETF worth $455K as of Q2 2026.
  • Aspiriant LLC sold 1,108 ProShares S&P 500 Dividend Aristocrats ETF shares in Q2 2026, an estimated $60K.
  • ProShares S&P 500 Dividend Aristocrats ETF made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #260 holding.
  • Aspiriant LLC first reported a position in ProShares S&P 500 Dividend Aristocrats ETF in Q2 2022 and has held it in 17 quarters since.
  • Aspiriant LLC's ProShares S&P 500 Dividend Aristocrats ETF position peaked at $560K in Q2 2023.
  • 191 funds tracked by Wall St. Rank held ProShares S&P 500 Dividend Aristocrats ETF as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.